Clinical Trial Results:
An exploratory phase IV, randomised, double-blind, placebo controlled crossover study to assess and compare the effects of 5 mg vs. 20 mg Desloratadine on the development of experimentally induced urticaria lesions
Summary
|
|
EudraCT number |
2005-006133-32 |
Trial protocol |
DE |
Global completion date |
11 May 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Sep 2020
|
First version publication date |
13 Sep 2020
|
Other versions |
|
Summary report(s) |
Link-to publication-PORTAL-study_2005-006133-32 manuscript-publication_study_2005-006133-32 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.